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Abstract: Palladium-catalyzed dehydrogenative coupling is an efficient synthetic strategy for
the construction of quinoline scaffolds, a privileged structure and prevalent motif in many
natural and biologically active products, in particular in marine alkaloids. Thus, quinolines and
1,2-dihydroquinolines can be selectively obtained in moderate-to-good yields via intramolecular
C–H alkenylation reactions, by choosing the reaction conditions. This methodology provides a direct
method for the construction of this type of quinoline through an efficient and atom economical
procedure, and constitutes significant advance over the existing procedures that require preactivated
reaction partners.
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1. Introduction
Marine organisms are an increasingly important source of bioactive natural products, which in
some cases have found application as pharmaceuticals (e.g., anticancer drugs) [1,2]. Quinoline core is a
common structural motif among many marine alkaloids [3,4]. For example, the pyridoacridine family
(e.g., ascididemin), a large class of marine alkaloids isolated from sessile organisms (sponges, corals,
ascidians, bryozoans) [5,6], which display different types of biological activities, e.g., cytotoxicity,
production of reactive oxygen species (ROS), and topoisomerase inhibition [7–10]. Marinoquinolines
A–F are pyrroloquinolines isolated from gliding bacterium Ohtaekwangia kribbensis (Bacteroidetes) [11],
whereas Veranamine is a benzonaphthyridine isolated from Florida sponges, namely, Verongula rigida,
with significant antidepressant activity [12,13]. Besides, two quinoline alkaloid glycosides have been
isolated in Puerto Rico from extracts of the cyanobacterium Lyngbya majuscule [14,15] (Figure 1). On the
other hand, quinstatins, derived from dolastatin 10 (exceptionally anticancer drug contained in the sea
hare Dolabella auricularia) by replacing the C-terminal dolaphenine (Doe) unit with a carefully designed
quinoline, have been reported to be exceptional cancer cell growth inhibitors [16,17]. Cyanobacterial
metabolites calothrixins have shown their potential as human DNA topisomerase I poisons for their
cytotoxicity in cancer [18].
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Figure 1. Selected bioactive marine alkaloids bearing a quinoline core. 
The outstanding biological activities of these marine alkaloids have attracted the attention of 
numerous research groups working toward the total synthesis of members of these natural products 
or analogues, either to get enough quantities or to establish structure-activity relationships for drug 
development. For example, it has been claimed that synthetic 4-alkylcarbonylmethyl or 4-
alkoxycarbonylmethyl substituted quinolines show inhibitory activity against drug resistant 
Mycobacterium tuberculosis [19] and potent antimicrobial activity against Helicobacter pylori [20]. More 
recently, based on SAR studies, it has been demonstrated that the presence of a methoxyl group at C-
5 position of the quinoline nucleus is structural feature common to a new class of Enhancer of Zeste 
Homologue 2 (EZH2) inhibitors, which could be useful for the treatment of several cancer types 
(lymphoma, colon, prostate, breast, and lung cancer) (Figure 2) [21]. 
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Figure 2. Characteristic structural features of some bioactive quinoline alkaloid analogues. 
Therefore, the development of new methodologies for the synthesis of quinolines and their 
dihydro/tetrahydro counterparts is well documented in the literature [22–25]. Among the several 
variants for synthesis of quinolines, the palladium-mediated cyclization processes [26–29] and, in 
particular, the intramolecular Mizoroki–Heck reaction [30–33] stand out as valuable synthetic 
protocols. In our research program on quinoline synthesis [34–36], we have reported [37] an effective 
protocol for the synthesis of 2-substituted 4-alkylidenetetrahydroquinoline derivatives, which 
employs a 6-exo-trig Mizoroki–Heck cyclization of N-alkenyl-substituted 2-haloanilines (Figure 3a). 
When non-substituted alkenes are used, the reaction can be directed towards the formation of an 
exocyclic or endocyclic carbon-carbon double bond, while 4-alkylidenetehtrahydroquinolines are 
obtained regioselectively with substituted alkenes. However, the Fujiwara-Moritani reaction offers 
notable advantages over traditional cross-coupling chemistry [38–42]. Reactions can be performed 
under air atmosphere even in aqueous media, and there is no need to prepare specifically 
functionalized cyclization precursors (i.e., o-haloanilines). This transformation, also known as 
oxidative Mizoroki–Heck reaction, consists in a direct coupling between two C–H centers (an 
aromatic C–H bond and an olefinic C–H bond), so it can be considered as either a C–H activation 
reaction or a C–H olefination. The reaction is catalyzed by Pd(II) and an external oxidant is required 
Figure 1. Selected bioactive marine alkaloids bearing a quinoline core.
The outstanding biological activities of these marine alkaloids have attracted the attention
of numerous research groups working toward the total synthesis of members of these natural
products or analogues, either to get enough quantities or to establish structure-activity relationships
for drug development. For example, it has been claimed that synthetic 4-alkylcarbonylmethyl
or 4-alkoxycarbonylmethyl substituted quinolines show inhibitory activity against drug resistant
Mycobacterium tuberculosis [19] and potent antimicrobial activity against Helicobacter pylori [20].
More recently, based on SAR studies, it has been demonstrated that the presence of a methoxyl
group at C-5 position of the quinoline nucleus is structural feature common to a new class of Enhancer
of Zeste Homologue 2 (EZH2) inhibitors, which could be useful for the treatment of several cancer
types (lymphoma, colon, prostate, breast, and lung cancer) (Figure 2) [21].
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Mizoroki–Heck reaction, consists in a direct coupling between two C–H centers (an aromatic C–H
bond and an olefinic C–H bond), so it can be considered as either a C–H activation reaction or a
C–H olefination. The reaction is catalyzed by Pd(II) and an external oxidant is required to regenerate
the active catalytic species. Control of site selectivity is one of the most important challenges in
this chemistry because organic molecules can contain a wide variety of C–H bonds [43]. The most
common strategies for addressing this issue are the use of electronically activated substrates, directing
groups [44–46] or ligands [47–50], which are able to coordinate to the metal center and deliver the
catalyst to the targeted C–H bond. Intermolecular Fujiwara-Moritani reactions have received much
attention recently, but examples of intramolecular variants are still scarce [51]. In particular, a number
of reports have dealt with the construction of five membered rings via 5-exo-trig processes, and in many
cases, the alkenylation of electron-rich heteroarenes is involved [52,53]. For example, intramolecular
reaction of substituted N-phenylacrylamides catalyzed by Pd(II)-catalysts afforded oxindoles in
moderate to good yields [54]. However, 6-endo-trig cyclizations are rare in Fujiwara-Moritani reactions
and have been described only when the 5-exo process is blocked, not allowing the palladium hydride
elimination. Nevertheless, we have been able to complete an unprecedented selective 6-endo-trig
intramolecular C–H alkenylation of N-phenylacrylamides that led to 4-substituted quinolin-2[1H]-ones
(Figure 3b) [55]. The adequate choice of the catalyst, oxidant, and experimental conditions allowed
us to presumably change the steric and electronic properties around the metal center and direct the
reaction to the β-position of the unsaturated moiety.
In this work we describe the use of the intramolecular C–H alkenylation reaction of N-buten-3-
ylanilines for the synthesis of quinolines and dihydroquinolines, through 6-exo-trig cyclization
processes. Thus, starting from the same precursors, conditions will be selected to favor nitrogen
deprotection and oxidation to obtain the quinolines, or to avoid this over-oxidation and obtain
1,2-dihydroquinolines after isomerization of the double bond. The extension to different substitution
patterns on the alkene or on the aromatic ring will also be described.
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The study began with the intramolecular Fujiwara-Moritani reaction of the N-substituted N-
alkenylanilines 1a,b (Scheme 1). To check the viability of the reaction, we first carried out a 
stoichiometric reaction with 1 equiv. of Pd(OAc)2 in acetic acid at reflux. In both cases, the N-
protecting group was lost in the reaction, leading to quinoline 2a in low yield (12%) through a 6-exo-
trig cyclization, followed by isomerization of the double bond and aromatization. Pd(II)-catalytic 
conditions were subsequently investigated (Scheme 1, Table 1). Due to extensive decomposition 
observed at high temperature, Pd(II)-catalysis at room temperature was first studied. Pd(OAc)2 was 
initially used as Pd(II) source in acetic acid in the presence of p-toluenesulfonic acid, as these 
conditions have been found to be optimal for the cyclization of related amides [55]. Besides, among 
the wide range of oxidants that can be used for reoxidation of Pd(0) to Pd(II), we selected PhCO3tBu 
[56], Cu(OAc)2 [57], p-benzoquinone [58] and N-fluoro-2,4,6-trimethylpyridinium triflate (F+) [59] for 
this preliminary screening.  
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2. Results and Discussion
The study began with the intramolecular Fujiwara-Moritani reaction of the N-substituted
N-alkenylanilines 1a,b (Scheme 1). To check the viability of the reaction, we first carried out a
stoichiometric reaction with 1 equiv. of Pd(OAc)2 in acetic acid at reflux. In both cases, the N-protecting
group was lost in the reaction, leading to quinoline 2a in low yield (12%) through a 6-exo-trig cyclization,
followed by isomerization of the double bond and aromatization. Pd(II)-catalytic conditions were
subsequently investigated (Scheme 1, Table 1). Due to extensive decomposition observed at high
temperature, Pd(II)-catalysis at room temperature was first studied. Pd(OAc)2 was initially used
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as Pd(II) source in acetic acid in the presence of p-toluenesulfonic acid, as these conditions have
been found to be optimal for the cyclization of related amides [55]. Besides, among the wide
range of oxidants that can be used for reoxidation of Pd(0) to Pd(II), we selected PhCO3tBu [56],
Cu(OAc)2 [57], p-benzoquinone [58] and N-fluoro-2,4,6-trimethylpyridinium triflate (F+) [59] for this
preliminary screening.Mar. Drugs 2017, 15, 276 4 of 13 
 
 
Scheme 1. Pd(II)-catalyzed cyclization of 1a,b. 
Table 1. Optimization of cyclization conditions for 1a,b. 
Entry Substrate [Pd] [O] L (a) t (h) 2a Yield (%)
1 1a Pd(OAc)2 PhCO3tBu (b) - 24 19 
2 1a Pd(OAc)2 PhCO3tBu (b) L1 24 11 
3 1a Pd(OAc)2) PhCO3tBu (b) L2 24 5 
4 1b Pd(OAc)2 PhCO3tBu (b) - 5.5 12 
5 1b Pd(OAc)2 PhCO3tBu (b) L1 5.5 11 
6 1b Pd(OAc)2 PhCO3tBu (b) L2 5.5 9 
7 1a Pd(OAc)2 Cu(OAc)2 (c) - 24 36 
8 1a Pd(OAc)2 Cu(OAc)2 (c) L1 24 35 
9 1a Pd(OAc)2 Cu(OAc)2 (c) L2 24 14 
10 1b Pd(OAc)2 Cu(OAc)2 (c) - 5.5 20 
11 1b Pd(OAc)2 Cu(OAc)2 (c) L1 5.5 nr 
12 1b Pd(OAc)2) Cu(OAc)2 (c) L2 5.5 nr 
13 1a Pd(OAc)2 p-BQ (c) - 24 4 
14 1a Pd(OAc)2 p-BQ (c) L1 14 5 
15 1a Pd(OAc)2 p-BQ (c) L2 24 24 
16 1b Pd(OAc)2 p-BQ (c) - 24 10 
17 1b Pd(OAc)2 p-BQ (c) L1 24 19 
18 1b Pd(OAc)2 p-BQ (c) L2 24 8 
19 1a Pd(dba)2 PhCO3tBu (b) - 24 28 
20 1a Pd(dba)2 Cu(OAc)2 (c) - 24 54 
21 1a Pd(dba)2 p-BQ (c) - 24 15 
22 1a Pd(dba)2 F+ (c) - 24 18 
23 1a PdCl2(CH3CN)2 PhCO3tBu (b) - 24 56 
24 1a PdCl2(CH3CN)2 Cu(OAc)2 (c) - 48 20 
25 1b PdCl2(CH3CN)2 PhCO3tBu (b) - 3.5 55 
26 1b PdCl2(CH3CN)2 F+ (c) - 24 27 
(a) 20 mol %; (b) 1.2 equiv. Cu(OAc)2 (5 mol %) was used as co-oxidant; (c) 1 equiv. 
Thus, quinoline 2a was obtained at room temperature with generally low yields, irrespective the 
oxidant, although the reactions were faster (5.5 h vs. 24 h) when acetate 1b was used (Table 1, entries 
1, 4, 7, 10, 13, 16). The use of ligands for palladium to increase the reactivity was also studied. In this 
context, pyridine ligands have been shown to enhance not only the reaction rate but also the site 
selectivity in Pd(II)-catalyzed reactions, and they have been used in intramolecular reactions, in 
combination with different oxidants [54,60–62]. We selected two pyridine ligands: ethyl nicotinate 
(L1) and 3-cyanopyridine (L2). However, the addition of these ligands for palladium had a 
detrimental effect in combination of all oxidants used, except for p-benzoquinone, for which a slight 
increase of the reactivity was observed (Table 1, entries 13 vs. 15 and 16 vs. 17). Various Pd(II) sources 
were also tested and Pd(dba)2 was revealed as a better catalyst than Pd(OAc)2 (Table 1, entries 19–22 
vs. entries 1, 7, and 13). Finally, the best conditions implied the use of PdCl2(CH3CN)2 as Pd(II) source, 
and a combination of PhCO3tBu and Cu(OAc)2 (5 mol %) as oxidative system, affording 2a in moderate 
yields from both 1a and 1b, although the reaction was much faster with 1b (Table 1, entries 23 and 25). 
With these conditions in hand, the reaction was extended for the synthesis of quinolines with 
different substitution at C-4 (Scheme 2, Table 2). Thus, different electron withdrawing groups were 
incorporated in the alkene from 1a,b through cross metathesis to obtain 1c–1j (see Supplementary 
Sche e 1. Pd(II)-catalyzed cyclization of 1a,b.
Table 1. Optimization of cyclization conditions for 1a,b.
Entry Substrate [Pd] [O] L (a) t (h) 2a Yield (%)
1 1a ( )2 3t ) - 24 19
2 1a P ( c)2 3 ) 1 24 11
3 1a 2 3 ) L2 24 5
4 1b 3 ( ) - 5.5 12
5 1b ( ) 3 (b) 1 5.5 11
6 1b ( c) PhC 3tBu (b) L2 5.5 9
7 1a Pd( Ac) u( c)2 (c) - 24 36
8 1a Pd(OAc) Cu(OAc)2 (c) L1 24 35
9 1a Pd(OAc)2 Cu(OAc)2 (c) L2 24 14
10 1b Pd(OAc)2 Cu(OAc)2 (c) - 5.5 20
11 1b Pd(OAc)2 Cu(OAc)2 (c) L1 5.5 nr
12 1b Pd(OAc)2 Cu(OAc)2 (c) L2 5.5 nr
13 1a Pd(OAc)2 p-BQ (c) - 24 4
14 1a Pd(OAc)2 p-BQ (c) L1 14 5
15 1a Pd(OAc)2 p-BQ (c) L2 24 24
16 1b Pd(OAc)2 p-BQ (c) - 24 10
17 1b Pd(OAc)2 p-BQ (c) L1 24 19
18 1b Pd(OAc)2 p-BQ (c) L2 24 8
19 1a Pd(dba)2 PhCO3tBu (b) - 24 28
20 1a Pd(dba)2 Cu(OAc)2 (c) - 24 54
21 1a Pd(dba)2 p-BQ (c) - 24 15
22 1a ( a)2 F (c) - 24 18
23 1a l2( 3C )2 3t ) - 24 56
24 1a 2 3 )2 ( )2 c) 48 20
25 1b 2( 3C )2 3 ) 3.5 55
26 1b )2 (c) 24 27
(a) 20 mol %; (b) 1.2 equiv. Cu(OAc)2 (5 ) as used as co- xidant; (c) 1 equiv.
Thus, quinoline 2a was obtained at room temperature with generally low yields, irrespective
the oxidant, although the reactions were faster (5.5 h vs. 24 h) when acetate 1b was used (Table 1,
entries 1, 4, 7, 10, 13, 16). The use of ligands for palladium to increase the reactivity was also studied.
In this context, pyridine ligands have been shown to enhance not only the reaction rate but also the
site selectivity in Pd(II)-catalyzed reactions, and they have been used in intramolecular reactions,
in combination with different oxidants [54,60–62]. We selected two pyridine ligands: ethyl nicotinate
(L1) and 3-cyanopyridine (L2). However, the addition of these ligands for palladium had a detrimental
effect in combination of all oxidants used, except for p-benzoquinone, for which a slight increase of
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the reactivity was observed (Table 1, entries 13 vs. 15 and 16 vs. 17). Various Pd(II) sources were also
tested and Pd(dba)2 was revealed as a better catalyst than Pd(OAc)2 (Table 1, entries 19–22 vs. entries 1,
7, and 13). Finally, the best conditions implied the use of PdCl2(CH3CN)2 as Pd(II) source, and a
combination of PhCO3tBu and Cu(OAc)2 (5 mol %) as oxidative system, affording 2a in moderate
yields from both 1a and 1b, although the reaction was much faster with 1b (Table 1, entries 23 and 25).
With these conditions in hand, the reaction was extended for the synthesis of quinolines with
different substitution at C-4 (Scheme 2, Table 2). Thus, different electron withdrawing groups were
incorporated in the alkene from 1a,b through cross metathesis to obtain 1c–1j (see Supplementary
Materials). However, when phenylsulfonyl derivative 1d was submitted to the previously optimized
conditions, only low conversion (<10%) of the starting material was observed at rt (Table 2, entry 1),
while decomposition was also observed when higher temperature was used (entry 2). The use of a more
powerful oxidant, such as F+ and 70 ◦C were necessary to obtain 4-phenylsufonylmethylquinoline 2b
in moderate yield (Table 2, entry 4). The yield could be improved using the corresponding carbamate
1c as starting material (Table 2, entry 5). Similarly, acetamide 1f showed lower reactivity than the
corresponding carbamate 1e, since longer reaction time is needed to bring the reaction to completion
(Table 2, entries 6 and 7), even using a higher catalyst loading. In both cases 2c was obtained in
moderate yields. When F+ was substituted for PhCO3tBu as the oxidant, longer reaction times were
required to obtain 2c in lower yield (Table 2, entry 8). The scope of the reaction was further studied
using only substrates possessing a carbamate-protecting group 1g–1j due to their higher reactivity.
Thus, the reaction proceeded efficiently for the synthesis of quinolines 2d–e that bear different ester
moieties (Table 2, entries 10–12), but failed when a trisubstituted olefin was used (Table 2, entry 9).
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1 1d CH3 SO2Ph H PhCO3tBu (a) rt 24 2b (c) 
2 1d CH3 SO2Ph H PhCO3tBu (a) 70 24 2b (c),(d) 
3 1d CH3 SO2Ph H F+ (a) rt 24 2b (c),(d) 
4 1d CH3 SO2Ph H F+ (a) 70 24 2b 44 
5 1c OCH3 SO2Ph H F+ (a) 70 24 2b 61 
6 1e OCH3 CO2CH3 H F+ (a) 70 19 2c 54 
7 1f CH3 CO2CH3 H F+ (a),(b) 70 41 2c 54 
8 1f CH3 CO2CH3 H PhCO3tBu (a) 70 47 2c 32 
9 1g OCH3 CO2CH3 CH3 F+ (a) 70 21 - (d) 
10 1h OCH3 CO2CH2CF3 H F+ (a) 70 21 2d 46 
11 1i OCH3 CO2(CH2)11CH3 H F+ (a) 70 21 2e 50 
12 1j OCH3 CO2CH2Ph H F+ (a) 70 21 2f 62 
(a) 1.2 equiv. Cu(OAc)2 (5 mol %) was used as co-oxidant; (b) Additional 5 mol % of catalyst was added; 
(c) Minor formation of product observed by 1H NMR; (d) Decomposition. 
As has been shown, the intramolecular Fujiwara-Moritani reaction allows the synthesis of 4-
substituted quinolines through a 6-exo-trig cyclization followed by deprotection and aromatization. 
On the other hand, to apply this protocol for the synthesis of 1,2-dihydroisoquinolines, deprotection 
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reaction time (7.5 h vs. 25 h). An increase of the reaction temperature to 70 °C led to a more efficient 
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Table 2. Extension to substituted alkenes. Synthesis of quinolines 2b–f.
Entry Substrate R1 R2 R3 [O] T (◦C) t (h) 2 Yield (%)
1 1d CH3 SO2Ph H PhCO3tBu (a) rt 24 2b (c)
2 1d CH3 SO2Ph H PhCO3tBu (a) 70 24 2b (c),
3 1d CH3 SO2Ph H F+ (a) rt 24 2b (c),(d)
4 1d 3 SO2Ph H F+ (a) 70 24 2b 44
5 1c OCH3 SO2Ph H F+ (a) 70 24 2b 61
6 1e OCH3 CO2CH3 H F+ (a) 70 19 2c 54
7 1f CH3 CO2CH3 H F+ (a),(b) 70 41 2c 54
8 1f CH3 CO2CH3 H PhCO3tBu (a) 70 47 2c 32
9 1g OCH3 CO2CH3 CH3 F+ (a) 70 21 - (d)
10 1h OCH3 CO2CH2CF3 H F+ (a) 70 21 2d 46
11 1i OCH3 CO2(CH2)11CH3 H F+ (a) 70 21 2e 50
12 1j OCH3 CO2CH2Ph H F+ (a) 70 21 2f 62
(a) 1.2 equiv. Cu(OAc)2 (5 mol %) was used as co-oxidant; (b) Additional 5 mol % of catalyst was added; (c) Minor
formation of product observed by 1H NMR; (d) Decomposition.
As has been shown, the intramolecular Fujiwara-Moritani reacti n allows the synthesis of
4-substitut d quinolines through a 6-ex -trig cyclization followed by deprotection a d aromatiza i .
On the other hand, to apply this protocol for the synthesis of 1,2-dihy roisoquinolines, deprotection of
the nitrogen atom should be avoided, thus preventing furth r oxidation. This would imply he use of
milder r action conditi ns, avoiding the use of acetic acid as solvent [63]. After some experimentation,
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we found that the cyclization could be efficiently performed in dioxane at room temperature, using
p-benzoquinone as an oxidant in the presence of p-toluenesulfonic acid (Scheme 3). Under these
reaction conditions, both protecting groups in 1a and 1b were stable, and dihydroquinolines 3a and 3b
were obtained in good yields (Table 3, entries 1 and 3). Once again, the carbamate protected aniline
1a was more reactive than 1b, leading to a good yield of 3a in shorter reaction time (7.5 h vs. 25 h).
An increase of the reaction temperature to 70 ◦C led to a more efficient reaction, obtaining 3a in high
yield (89%) in only 10 min (Table 3, entry 2). Once again, the use of ligands L1 and L2 for palladium was
detrimental, completely precluding the reaction. Then, the extension to other substitution patterns on
the aromatic ring was studied. Interestingly, with a more electron rich aromatic ring (1k), the reaction
was less efficient, and no cyclization was observed at room temperature after 24 h (Table 3, entry 6).
An increase of the temperature was required to obtain 3c in low yield (Table 3, entry 7), which could
be improved increasing the catalyst loading (Table 3, entry 8), although an increase of the reaction
time led to decomposition, lowering the isolated yield of 3c (Table 3, entry 9). An electron-donor
group ortho to the cyclization position appears to be necessary, as the reaction did not proceed at all
for the 3,4-disubstituted substrates 1l and 1m (Table 3, entries 10 and 11). However, when weakly
donor methyl groups are incorporated in 3,5-positions, the cyclization took place, but in this case
isomerization of the double bond led to the formation of the 1,4-dihydroquinoline 4d.
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metalation deprotonation (CMD), oxidative addition or electrophilic palladation mechanisms have 
been proposed. In this case, the electronic effects of the substituents on the aromatic ring would agree 
with an electrophilic palladation mechanism, favored by the electron-donor effects of the substituents 
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Table 3. Synthesis of 4-substituted dihydroquinolines 3a–c and 4d.
Entry Substrate R1 R2 R3 R4 T (◦C) t (h/min) Product Yield (%)
1 1a OCH3 OCH3 H OCH3 rt 7.5 h 3a 74
2 1a OCH3 OCH3 H OCH3 70 10 min 3a 89
3 1b CH3 OCH3 H OCH3 rt 25 h 3b 62
4 1b CH3 OCH3 H OCH3 rt (a) 23 h - (c)
5 1b CH3 OCH3 H OCH3 rt (b) 23 - (c)
6 1k OCH3 OCH3 OCH3 OCH3 rt - )
7 1k OCH3 OCH3 OCH3 OCH3 70 2 h 3c 33
8 1k OCH3 OCH3 OCH3 OCH3 70 (d) 2 h 3c 40
9 1k OCH3 OCH3 OCH3 OCH3 70 (d) 7 h 3c 11
10 1l OCH3 H OCH2O 70 (d) 24 h - (c)
11 1m OCH3 H OCH3 OCH3 70 (d) 24 h - (c)
12 1n OCH3 CH3 H CH3 70 (d) 4d 32
(a) L1 (5 mol %) was added; (b) L2 (5 mol %) was added; (c) No reaction. Recovered starting material; (d) 10 mol % of
catalyst was used.
These results are in agreement with the mechanistic proposal shown in Scheme 4. Thus, the first
step would be the formation if the arylpalladium(II) intermediate I. Different mechanisms have been
proposed for this palladation step, which is highly dependent on the substrate [50]. Thus, concerted
metalation deprotonation (CMD), oxidative addition or electrophilic palladation mechanisms have
been proposed. In this case, the electronic effects of the substituents on the aromatic ring would agree
with an electrophilic palladation mechanism, favored by the electron-donor effects of the substituents
on the aromatic ring. The subsequent migratory insertion followed by β-hydride elimination would
form quinoline II, with an exocyclic double bond that would isomerize to the endocyclic position
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forming 3, probably due to a higher thermodynamic stability. Pd(0) is finally oxidized to the Pd(II)
active species by the oxidant.Mar. Drugs 2017, 15, 276 7 of 13 
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In conclusion, it has been shown that both quinolines and 1,2-dihydroquinolines can be selectively
obtained in moderate to good yields via palladium(II)-catalyzed C–H alkenylation reactions, choosing
the reaction conditions. Thus, when the reactions are carried out in acetic acid, deprotection and
further oxidation leads to the one pot formation of 4-substituted quinolines 2a–f. On the other
hand, under milder reaction conditions, deprotection and over-oxidation can be avoided, leading
to 1,2-dihydroquinolines 3a–c. This procedure is complementary to the related Mizoroki-Heck
reaction [37] that led to the formation of 4-methylidenetetrahydroquinolines, with exocyclic double
bonds, with the advantage that this procedure does not require the prior functionalization of the
substrates. However, the method is so far limited to the use of electron rich aromatic rings.
3. Materials and Methods
3.1. General Experimental Methods
Melting points were determined in unsealed capillary tubes and are uncorrected. IR spectra
were obtained in film over NaCl pellets, or using an ATR. NMR spectra were recorded at 20–25 ◦C,
at 300 MHz for 1H and 75.5 MHz for 13C or at 500 MHz for 1H and 125.7 MHz for 13C in CDCl3
solutions. Assignments of individual 13C and 1 resonances are supported by DEPT experiments and
2D correlation experiments (COSY, HSQCed or HMBC). Selective NOE or NOESY experiments were
performed when necessary. Mass spectra were recorded under electron impact (EI) at 70 eV or under
chemical ionization (CI) at 230 eV, or using Electrospray ionization (ESI+). Exact mass was obtained
using a TOF detector. TLC was carried out with 0.2 mm thick silica gel plates. Visualization was
accomplished by UV light. Flash column chromatography was performed on silica gel (230–400 mesh)
or on alumina (70–230 mesh). All solvents used in reactions were anhydrous and purified according
to standard procedures. All air- or moisture-sensitive reactions were performed under argon;
the glassware was dried (130 ◦C) and purged with argon. Palladium catalysts were purchased from
Sigma-Aldrich Química SL (Madrid, Spain), and were used without further purification: Pd(OAc)2
98% purity, PdCl2(CH3CN)2, 99% purity.
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3.2. Synthesis of 4-Substituted Quinolines 2
5,7-Dimethoxy-4-methylquinoline (2a) (Table 1, entry 23). Over a solution of methyl but-3-en-1-yl(3,5-
dimethoxyphenyl)carbamate (1a) (94.3 mg, 0.36 mmol) in AcOH (1.4 mL), PhCO3tBu (0.09 mL,
0.43 mmol), Cu(OAc)2 (3.3 mg, 0.018 mmol), TsOH (64.8 mg, 0.36 mmol) and PdCl2(CH3CN)2 (4.7 mg,
0.018 mmol) were added. The mixture was stirred at room temperature for 24 h, and then the solvent
was removed under vacuum. The residue was dissolved in AcOEt (5 mL) and it was washed with a 2 M
aqueous solution of Na2CO3 (2 × 10 mL) and brine (2 × 10 mL). The aqueous phase was re-extracted
with AcOEt (10 mL) and the combined organic extracts were dried (Na2SO4) and concentrated in vacuo.
Flash column chromatography (silica gel, hexane/AcOEt 6/4) afforded 23 (40.3 mg, 56%) as an oil: IR
(ATR) 1612 cm−1 (C=N); 1H NMR (CDCl3): δ 2.81 (s, 3H, CH3), 3.89 (s, 3H, OCH3), 3.92 (s, 3H, OCH3),
6.48 (d, J = 2.3 Hz, 1H, H6), 6.95 (d, J = 4.5 Hz, 1H, H3), 7.02 (d, J = 2.3 Hz, 1H, H8), 8.56 (d, J = 4.5 Hz,
1H, H2); 13C NMR (CDCl3): δ 24.3 (CH3), 55.5 (2 × OCH3), 98.6 (C6), 100.4 (C3), 116.8 (C4a), 121.4 (C8),
146.0 (C4), 150.0 (C2), 151.35 (C8a), 158.6 (C5), 160.4 (C7); MS (EI) m/z (rel intensity) 204.1 (M+ + 1, 13),
203.1 (M+, 100), 188 (28), 174.1 (12), 160.1 (11), 145 (14), 117 (11); HRMS (CI) calcd. for C12H14NO2
[MH+], 204.1025; found: 204.1025.
General Procedure for the Synthesis of 4-Substituted Quinolines 2b–f
Over a solution of the corresponding butenyl aniline 1c–j (1 mmol) in AcOH (11 mL), TsOH
(1 mmol), N-fluoro-2,4,6-trimethylpyridinium triflate (F+) (1.2 mmol), Cu(OAc)2 (0.05 mmol) and
PdCl2(CH3CN)2 (0.05 or 0.1 mmol) were added. The mixture was stirred at 70 ◦C for the specified time,
and then the solvent was removed under vacuum. The residue was dissolved in AcOEt (5 mL) and it
was washed with a 2 M aqueous solution of Na2SO4 (2 × 10 mL) and brine (2 × 10 mL). The aqueous
phase was re-extracted with AcOEt (10 mL) and the combined organic extracts were dried (Na2SO4)
and concentrated in vacuo. Flash column chromatography (silica gel, hexane/AcOEt) afforded the
corresponding quinolines 2b–f (Table 2).
5,7-Dimethoxy-4-[(phenylsulfonyl)methyl]quinoline (2b) (Table 2, entry 5). Prepared from 1c (68.7 mg,
0.17 mmol), TsOH (32.7 mg, 0.17 mmol), F+ (59.4 mg, 0.20 mmol), Cu(OAc)2 (1.6 mg, 0.008 mmol)
and PdCl2(CH3CN)2 (2.2 mg, 0.008 mmol) in AcOH (1.5 mL). The mixture was stirred at 70 ◦C for
24 h. After work-up and purification by flash column chromatography (silica gel, hexane/AcOEt 2/8),
2d was obtained (35.3 mg, 61%) as an oil: IR (ATR) 1620 cm−1 (C=N), 1325 cm−1, 1135 cm−1 (R-SO2-R);
1H NMR (CDCl3): δ 3.71 (s, 3H, OCH3), 3.91 (s, 3H, OCH3), 5.22 (s, 2H, CH2), 6.36 (d, J = 2.4 Hz, 1H,
H6), 7.01–7.05 (m, 2H, H3, H8), 7.28–7.37 (m, 2H, H3′ , H5′ ), 7.46–7.53 (m, 3H, H2′ , H4′ , H6′ ), 8.69 (d,
J = 4.5 Hz, 1H, H2); 13C NMR (CDCl3): δ 55.5 (OCH3), 55.6 (OCH3), 62.0 (CH2), 99.7 (C6), 101.1 (C8),
115.2 (C4a), 123.5 (C3), 128.6 (C2′ , C3′ , C5′ , C6′ ), 133.6 (C4′ ), 134.1 (C4), 138.4 (C1′ ), 149.9 (C2), 151.7 (C8a),
156.7 (C5), 160.5 (C7); MS (ESI+) m/z (rel intensity) 345.1 (MH+ + 1, 19), 344.1 (MH+, 100); HRMS (ESI+)
calcd. for C18H18NO4S [MH+], 344.0957; found: 344.0970.
Methyl 2-(5,7-dimethoxyquinolin-4-yl)acetate (2c) (Table 2, entry 6). Prepared from 1e (93.3 mg, 0.29 mmol),
TsOH (54.9 mg, 0.29 mmol), F+ (0.10 g, 0.35 mmol), Cu(OAc)2 (2.6 mg, 0.014 mmol) and PdCl2(CH3CN)2
(3.7 mg, 0.014 mmol) in AcOH (3.2 mL). The mixture was stirred at 70 ◦C for 19 h. After work-up
and purification by flash column chromatography (silica gel, hexane/AcOEt 2/8), 2c was obtained
(40.8 mg, 54%) as a solid: mp (CH2Cl2) 77–80 ◦C; IR (ATR) 1735 cm−1(C=O); 1H NMR (CDCl3): δ 3.67
(s, 3H, COOCH3), 3.83 (s, 3H, OCH3), 3.91 (s, 3H, OCH3), 4.09 (s, 2H, CH2COOCH3), 6.49 (d, J = 2.2 Hz,
1H, H6), 6.95 (d, J = 4.4 Hz, 1H, H3), 7.02 (d, J = 2.2 Hz, 1H, H8), 8.67 (d, J = 4.4 Hz, 1H, H2); 13C NMR
(CDCl3): δ 42.8 (CH2COOCH3), 51.8 (COOCH3), 55.2 (OCH3), 55.5 (OCH3), 99.0 (C6), 100.9 (C8), 116.0
(C4a), 122.2 (C3), 140.2 (C4), 150.4 (C2), 151.6 (C8a), 157.2 (C5), 160.5 (C7), 171.4 (CO); MS (EI) m/z
(rel intensity) 262.1 (M+ + 1, 17), 261.2 (M+, 100), 229.1 (12), 202.1 (10), 186.1 (19), 172.1 (36); HRMS
(ESI+) calcd. for C14H16NO4 [MH+], 262.1079; found: 262.1091.
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2,2,2-Trifluoroethyl 2-(5,7-dimethoxyquinolin-4-yl)acetate (2d) (Table 2, entry 10). Prepared from 1h (0.15 g,
0.39 mmol), TsOH (73.4 mg, 0.39 mmol), F+ (0.13 g, 0.46 mmol), Cu(OAc)2 (3.5 mg, 0.019 mmol) and
PdCl2(CH3CN)2 (5.0 mg, 0.019 mmol) in AcOH (4.3 mL). The mixture was stirred at 70 ◦C for 21 h.
After work-up and purification by flash column chromatography (silica gel, hexane/AcOEt 2/8),
6b was obtained (58.3 mg, 46%) as a solid: mp (CH2Cl2) 95–97 ◦C; IR (ATR) 1745 cm−1(C=O); 1H NMR
(CDCl3): δ 3.81 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 4.19 (s, 2H, CH2COOCH2), 4.48 (q, J = 8.5 Hz, 2H,
COOCH2CF3), 6.50 (d, J = 2.2 Hz, 1H, H6), 6.95 (d, J = 4.4 Hz, 1H, H3), 7.06 (d, J = 2.2 Hz, 1H, H8),
8.67 (d, J = 4.4 Hz, 1H, H2); 13C NMR (CDCl3): δ 42.2 (CH2COOCH2), 55.3 (OCH3), 55.6 (OCH3),
60.5 (q, J = 36.6 Hz, COOCH2CF3), 99.3 (C6), 100.8 (C8), 115.8 (C4a), 122.3 (C3), 112.9 (q, J = 275.8 Hz,
CF3), 139.2 (C4), 150.3 (C2), 151.5 (C8a), 157.0 (C5), 160.7 (C7), 169.5 (CO); MS (EI) m/z (rel intensity)
330.1 (M+ + 1, 17), 329.1 (M+, 100), 186 (21), 172.1 (27); HRMS (ESI+) calcd. for C15H15F3NO4 [MH+],
330.0953; found: 330.0956.
Dodecyl 2-(5,7-dimethoxyquinolin-4-yl)acetate (2e) (Table 2, entry 11). Prepared from 1i (0.14 g,
0.29 mmol), TsOH (54.3 mg, 0.29 mmol), F+ (99.1 mg, 0.34 mmol), Cu(OAc)2 (3.1 mg, 0.017 mmol)
and PdCl2(CH3CN)2 (4.4 mg, 0.017 mmol) in AcOH (3.2 mL). The mixture was stirred at 70 ◦C for
21 h. After work-up and purification by flash column chromatography (silica gel, hexane/AcOEt 3/7),
2f was obtained (59.5 mg, 50%) as a solid: mp (CH2Cl2) 54–56 ◦C; IR (ATR) 1731 cm−1 (C=O); 1H NMR
(CDCl3): δ 0.87 (t, J = 6.7 Hz, 3H, CH3), 1.10–1.35 (m, 18H, OCH2CH2(CH2)9CH3), 1.42–1.64 (m, 2H,
CO2CH2CH2), 3.83 (s, 3H, OCH3), 3.91 (s, 3H, OCH3), 4.05 (t, J = 6.7 Hz, 2H, COOCH2), 4.09 (s, 2H,
CH2COOCH2), 6.49 (d, J = 1.7 Hz, 1H, H6), 6.96 (d, J = 4.1 Hz, 1H, H3), 7.08 (d, J = 1.7 Hz, 1H, H8), 8.67
(br s, 1H, H2); 13C NMR (CDCl3): δ 14.1 (CH3), 22.7 (CH3CH2), 25.9 (COOCH2CH2CH2), 28.6, 29.2,
29.3, 29.5, 29.6, 29.7 (7 × CH2), 31.9 (CH3CH2CH2), 43.2 (CH2COOCH2), 55.2 (OCH3), 55.5 (OCH3),
64.9 (COOCH2), 99.0 (C6), 100.9 (C8), 116.0 (C4a), 122.2 (C3), 140.5 (C4), 150.4 (C2), 151.6 (C8a), 157.2
(C5), 160.5 (C7), 171.0 (CO); MS (EI) m/z (rel intensity) 416.3 (M+ + 1, 8), 415.3 (M+, 30), 386.3 (24), 372.2
(23), 358.2 (21), 344.2 (18), 330.2 (18), 316.2 (21), 302.1 (21), 248.1 (12), 247.1 (10), 204.1 (11), 203.1 (72),
202.1 (25), 189.1 (10), 188.1 (100), 173.1 (18), 172.1 (56), 129 (10), 57.1 (12), 55.1 (19); HRMS (ESI+) calcd.
for C25H38NO4 [MH+], 416.2801; found: 416.2809.
Benzyl 2-(5,7-dimethoxyquinolin-4-yl)acetate (2f) (Table 2, entry 12). Prepared from 1j (0.11 g, 0.28 mmol),
TsOH (53.9 mg, 0.28 mmol), F+ (98.3 mg, 0.34 mmol), Cu(OAc)2 (2.6 mg, 0.014 mmol) and
PdCl2(CH3CN)2 (3.7 mg, 0.014 mmol) in AcOH (3.1 mL). The mixture was stirred at 70 ◦C for 21 h.
After work-up and purification by flash column chromatography (silica gel, hexane/AcOEt 2/8),
2g was obtained (58.9 mg, 62%) as an oil: IR (ATR) 1735 cm−1 (C=O); 1H NMR (CDCl3): δ 3.54 (s, 3H,
OCH3), 3.92 (s, 3H, OCH3), 4.12 (s, 2H, CH2COOCH2Ph), 5.12 (s, 2H, CH2Ph) 6.41 (d, J = 2.3 Hz, 1H,
H6), 6.97 (d, J = 4.5 Hz, 1H, H3), 7.06 (d, J = 2.3 Hz, 1H, H8), 7.14-7.49 (m, 5H, Ph), 8.67 (d, J = 4.5 Hz,
1H, H2); 13C NMR (CDCl3): δ 43.1 (CH2COOCH2Ph), 54.9 (OCH3), 55.5 (OCH3), 66.3 (CH2Ph), 99.0
(C6), 100.8 (C8), 116.0 (C4a), 122.3 (C3), 128.2 (C2′ , C6′ ), 128.5 (C3′ , C4′ , C5′ ), 136.0 (C1′ ), 140.2 (C4), 150.4
(C2), 151.6 (C8a), 157.1 (C5), 160.5 (C7), 170.7 (CO); MS (EI) m/z (rel intensity) 338.1 (M+ + 1, 20), 337.1
(M+, 92), 172.1 (47), 91.1 (100); HRMS (ESI+) calcd. for C20H20NO4 [MH+], 338.1392; found: 338.1418.
3.3. Synthesis of 4-Substituted Dihydroquinolines 3 and 4
General Procedure
Over a solution of the corresponding N-substituted but-3-en-1-ylaniline 1a,b,k–n (1 mmol) in
dioxane (66.7 mL), TsOH (1 mmol), p-benzoquinone (1 mmol) and PdCl2(CH3CN)2 (0.05 mmol)
were added. The reaction mixture was stirred for the specified time at room temperature or at
70 ◦C. Afterwards, water was added to quench the reaction and the mixture was extracted with
CH2Cl2 (3 × 10 mL). The combined organic extracts were washed with brine (10 mL), dried (Na2SO4)
and concentrated in vacuo. Flash column chromatography (silica gel, hexane/AcOEt) afforded the
corresponding 1,2-dihydroquinoles 3a–c or 1,4-dihydroquinoline 4d.
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Methyl 5,7-dimethoxy-4-methylquinoline-1(2H)-carboxylate (3a) (Table 3, entry 2). Prepared from
carbamate 1a (106.5 mg, 0.40 mmol), TsOH (77.5 mg, 0.40 mmol), p-benzoquinone (44.1 mg, 0.40 mmol)
and PdCl2(CH3CN)2 (5.3 mg, 0.020 mmol) in dioxane (31 mL). The reaction mixture was stirred
for 10 min at 70 ◦C and after work-up and purification by flash column chromatography (silica gel,
hexane/AcOEt 8/2), 3a was obtained (94.2 mg, 89%) as an oil: IR (ATR) 1706 cm−1 (C=O); 1H NMR
(CDCl3): δ 2.16 (d, J = 1.3 Hz, 3H, CH3) 3.77 (s, 3H, COOCH3), 3.79 (s, 3H, OCH3), 3.81 (s, 3H, OCH3),
4.10–4.15 (m, 2H, CH2), 5.64 (td, J = 4.8, 1.3 Hz, 1H, H3), 6.29 (d, J = 2.4 Hz, 1H, H6), 6.80 (br s, 1H,
H8); 13C NMR (CDCl3): δ 21.9 (CH3), 42.7 (C2), 53.0 (COOCH3), 55.4 (OCH3), 55.5 (OCH3), 96.1 (C6),
101.4 (C8), 113.6 (C4a), 119.9 (C3), 132.7 (C4), 139.4 (C8a), 154.4 (CO), 158.0 (C5), 159.0 (C7); MS (EI) m/z
(rel intensity) 264.1 (M+ + 1, 13), 263.1 (M+, 79), 249.1 (14), 248.1 (100), 205.1 (11), 204.1 (84), 203.1 (50),
189.1 (29), 188.1 (24), 174.1 (13), 160.1 (16), 146.1 (11), 145.1 (11), 130.1 (10), 117.1 (10); HRMS (ESI+)
calcd. for C14H18NO4 [MH+], 264.1236; found: 264.1259.
1-[5,7-Dimethoxy-4-methylquinolin-1(2H)-yl]ethanone (3b) (Table 3, entry 3). Prepared from acetamide
1b (0.12 g, 0.46 mmol), TsOH (88.1 mg, 0.46 mmol), p-benzoquinone (50.1 mg, 0.46 mmol) and
PdCl2(CH3CN)2 (6.0 mg, 0.023 mmol) in dioxane (31 mL). The reaction mixture was stirred for 25 h
at rt, and after work-up and purification by flash column chromatography (silica gel, hexane/AcOEt
6/4), 3b was obtained (71.2 mg, 62%) as a mixture of rotamers in a 6:4 ratio and as an oil: IR (ATR)
1699 (C=O); 1H NMR (CDCl3): δ 2.19 (s, 3H, CH3, both rotamers), 2.23 (s, 3H, COCH3, both rotamers),
3.83 (s, 6H, 2 × OCH3, both rotamers), 4.21 (br s, 2H, CH2, both rotamers), 5.71 (br s, 6.36, major
rotamer: 2H, H6, H8; minor rotamer: 1H, H6), 6.75 (br s, 1H, H8, minor rotamer); 13C NMR (CDCl3): δ
21.9 (CH3, both rotamers), 22.7 (COCH3, both rotamers), 40.9 (C2, both rotamers), 55.4 (OCH3, both
rotamers), 55.5 (OCH3, both rotamers), 96.5 (C6, both rotamers), 102.3 (C8, major rotamer), 114.1 (C4a,
both rotamers), 116.1 (C8, minor rotamer), 122.2 (C3, both rotamers), 132.2 (C4, both rotamers), 139.9
(C8a, minor rotamer), 149.84 (C8a, major rotamer), 157.8 (C5, both rotamers), 158.8 (C7, both rotamers),
169.7 (CO, both rotamers); MS (EI) m/z (rel intensity) 248.1 (M+ + 1, 3), 247.1 (M+, 18), 205.1 (15),
204.1 (100), 203.1 (10), 190.1 (28), 189.1 (19); HRMS (ESI+) calcd. for C14H18NO3 [MH+], 248.1287,
found: 248.1294.
Methyl 5,6,7-trimethoxy-4-methylquinoline-1(2H)-carboxylate (3c) (Table 3, entry 8). Prepared from
carbamate 1k (0.107 g, 0.36 mmol), TsOH (70 mg, 0.36 mmol), p-benzoquinone (40 mg, 0.36 mmol) and
PdCl2(CN)2 (9.5 mg, 0.036 mmol) in dioxane (31 mL). The reaction mixture was stirred for 2 h at 70 ◦C,
and after work-up and purification by flash column chromatography (silica gel, hexane/AcOEt 6/4)
affording 3c as an oil (42 mg, 40%): IR (ATR) 1685 cm−1 (C=O); 1H NMR (CDCl3): δ 2.18 (s, 3H, CH3),
3.77 (s, 3H, CO2CH3), 3.82 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 4.11 (brs, 2H, NCH2),
5.69 (brs, 1H, H3), 6.98 (br s, 1H, H8); 13C NMR (CDCl3): δ 21.3 (CH3), 42.6 (C2), 53.0 (CO2CH3), 56.0
(OCH3), 60.8 (OCH3), 61.1 (OCH3), 104.3 (C8), 117.8 (C4a), 121.2 (C3), 132.2 (C4), 133.5 (C8a), 139.8 (C6),
150.8 (C5), 151.9 (C7), 154.5 (CO); MS (EI) m/z (rel intensity): 293 (M+, 69), 278 (100), 262 (8), 234 (40),
218 (24), 207 (27), 204 (21), 190 (17), 176 (13); HRMS (ESI+) calcd. for C15H20NO5 [M + H]+, 294.1341;
found: 294.1361.
Methyl 4,5,7-trimethylquinoline-1(4H)-carboxylate (4d) (Table 3, entry 12). Prepared from carbamate
1n (110.0 mg, 0.47 mmol), TsOH (91.1 mg, 0.47 mmol), p-benzoquinone (52.0 mg, 0.47 mmol) and
PdCl2(CN)2 (12.4 mg, 0.047 mmol) in dioxane (31 mL). The reaction mixture was stirred for 24 h at
70 ◦C, and after work-up and purification by flash column chromatography (silica gel, hexane/AcOEt
9:1) affording the product 4d as an oil (34.4 mg, 32%): IR (ATR) 1730 cm−1 (C=O); 1H NMR (CDCl3):
δ 1.16 (d, J = 6.9 Hz, 3H, CHCH3), 2.29 (s, 3H, CH3), 2.31 (s, 3H, CH3), 3.44–3.52 (m, 1H, H4), 3.87 (s,
3H, OCH3), 5.48 (t, J = 6.9 Hz, 1H, H3), 6.84 (s, 1H, H6), 6.95 (d, J = 6.9 Hz, 1H, H2), 7.62 (s, 1H, H8);
13C NMR (CDCl3): δ 18.7 (CHCH3), 21.2 (CH3), 29.0 (C4), 53.1 (OCH3), 116.3 (C3), 120.3 (C8), 125.9 (C6),
127.8 (C4a), 129.4 (C2), 134.6 (C8a), 135.3 (C7), 136.1 (C5), 153.3 (CO); MS (EI) m/z (rel intensity): 231
(M+, 65), 215 (100), 199 (8), 171 (84), 156 (21); HRMS (ESI+) calcd. for C14H18NO2 [M + H]+, 232.1338;
found: 232.1344.
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